Dupilumab 200 mg was efficacious in children (6–11 years) with moderate‐to‐severe asthma for up to 2 years: EXCURSION open‐label extension study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Wanda Phipatanakul, Christian Vogelberg, Leonard B. Bacharier, Sharon Dell, Arman Altincatal, Rebecca Gall, Oliver Ledanois, Harry Sacks, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Pediatric Pulmonology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet